HeilaArt

For

Musculoskeletal Disorders

Product Definition

Osteoarthritis is degenerative joint disease caused by an imbalance in joint environment in which inflammatory and destructive elements overcome regenerative factors. This lack of regenerative power may lead to cartilage damage which is characterized by features such as joint pain, swelling, stiffness and deformity. HeilaArt is a natural intensifier for regenerative forces. HeilaART extract, purify and empower multiple regenerative molecules (growth factors) and an important anti-inflammatory (anti-destructive) factor, called “interleukin 1 receptor blocker” from your own blood. These molecules are able to reduce destruction of joint cartilage and promote tissue regeneration.
  1. HeilaART therapy is an autologous (from patient's own blood), natural (without any added medication or element) method.
  2. HeilaART is a cell-free serum containing high doses of more than 8 growth factors which are responsible for tissue regeneration in human body.
  3. HeilaART is a cell-free serum containing powerful anti-inflammatory molecule, interleukin-1 receptor blocker, which could be used as an effective anti-inflammatory medication in musculoskeletal disorders.
  4. HeilaART is suitable for patients with corticosteroid contraindications such as diabetes mellitus.
  5. HeilaART is an appropriate alternative for corticosteroids in sport-related injuries of professional athletes.
  6. HeilaART pain relief and anti-inflammatory effects maintains up to 12 months in treated patients.
  7. HeilaART is safe with no reported serious, life-threatening complications.
  1. HeilaART is a natural product, with no external additives. It is compatible with your immune system and has no allergic reaction.
  2. HeilaART enhance joint repair by promoting cartilage survival and reduction of inflammation. Safety and efficacy of HeilaART is demonstrated in clinical trials.
  3. HeilaART preparation method is simple with similar results on each try.

How it Works

1
Draw

Draw Patient’s blood by Syringe

2
Let

Let Blood Cells interact with BPT for 8 hours

3
Extract

Extract The Enriched Autologous Serum (ACS) from the blood

4
Inject

Inject the Serum to the Target Lesion

More Details ...

20 ml (two HeilaART kits) of your blood is drawn (similar to lab test sampling), incubated and centrifuged to enrich and extract natural regenerative molecules (growth factors and anti-inflammatory cytokines).

A pure autologous serum is prepared with high concentrations of your natural growth factors.

The serum is injected in affected joint, tendon or muscle, weekly for a period of 4 weeks.

HeilaART therapy is an out-patient process with no need for anesthesia.

There would be reports of localized pain or swelling in treated joint in some patients, which are limited and controlled by conservative management.

Need More Information

What is ACS (Autologous Conditioned Serum)
ACS refers to a processed serum, obtained from patient’s own blood. ACS contains multiple highly concentrated innate proteins which are extracted from blood cells. These proteins have proven efficacy for prevention, treatment and alleviation of various chronic disorders in human and animals. No chemicals or drug are integrated with ACS during processing phase. ACS is safe with near to zero possibility of side effects for the patients.
More ...
What is BPT and how can make a unique ACS?
Black Pearl Technology (BPT) is the latest generation of kits, designed for preparation of ACS in the world. BPT is a modified blood-taking syringe, containing coated glass beads. These glass beads are responsible to have a safe interaction with human blood cells and production of required proteins. More ...
PRP Vs. ACS/BPT
ACS/BPT is more clinically powerful, less invasive for the patient and has fewer reported side effects in comparison to platelet-rich plasma (PRP) in medical literature. More ...
Roham Cell Teb (RC Teb), is a medical technology company focused on the field of regenerative medicine. The technology stimulates human or animal blood cells to produce and release growth factors and regenerative cytokines that accelerates the regeneration of soft tissues.
MLT AIKINS LLP 30th Floor, 360 Main Str. Winnipeg MB R3C 4G1

Our Patent

A provisional utility patent (WO2022029464) has been authored, filed, and published for “The Bioactivity of Carboniuos NanopRCTeb Ltd.les in Enrichment of Blood With Growth Factors: The Black Pearl Technology” This patent takes into account both offensive and defensive postures in its claims.
The patent can be found here

Contact Us